We work with the Myanmar Ministry of Health to provide care for HIV and TB patients, primary healthcare, and vaccinations.

We remain the main provider of HIV care in Dawei, Tanintharyi region, treating people with the disease. Teams are targeting high-risk and vulnerable groups, such as sex workers, men who have sex with men and migrant workers, and supporting the National AIDS Programme (NAP) to decentralise treatment.

In addition, we treat HIV patients co-infected with diseases such as tuberculosis, cytomegalovirus retinitis and hepatitis C.

Due to a worsening political situation and our inability to secure access for international staff to work in the region, medical activities in Wa Special Region 2 are limited.

Despite this, in the remote Pang Yang and Lin Haw townships, where access to healthcare is minimal, we provide outpatient consultations through fixed and mobile clinics and support Ministry of Health vaccination campaigns.

 
MSF Medical Action - Rohingya Crisis
Rohingya refugee crisis

Immediate action needed to avert massive public health disaster

Press Release 21 Sep 2017
 
Rohingyas Fleeing into Bangladesh
Rohingya refugee crisis

International humanitarian access to Rakhine State must urgently be permitted

Press Release 18 Sep 2017
 
Falling into the gap HIV+ adolescents - WAD 2016
Myanmar

Don't let adolescents with HIV slip away

Project Update 29 Nov 2016
 

Flood victims vulnerable to dengue fever

Project Update 17 Aug 2015
 
Myanmar

MSF assisting thousands as worst flooding in decades hits parts of the country

Project Update 4 Aug 2015
 
MDR-TB treatment MSF Clinic Yangon, Myanmar
Tuberculosis

The Luxury of MDR-TB treatment in Myanmar: An impossible choice for many

Voices from the Field 20 Mar 2015
 
Myanmar

MSF restarts basic medical activities in parts of Myanmar’s Rakhine State after nine-month absence

Press Release 20 Jan 2015
 
Myanmar

MSF welcomes offer to resume operations in Rakhine, Myanmar but remains cautious

Press Release 25 Jul 2014
 
Myanmar

First patients take oral drug for HIV-related blindness

Press Release 23 Jul 2014